Ubs Asset Management Americas Inc 10x Genomics, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,116,573 shares of TXG stock, worth $25.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,116,573

Previous 1,922,985 10.07%

Holding current value

$25.6 Million

Previous $43.4 Million 30.0%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $2.55 Million - $4.13 Million	193,588 Added 10.07%	2,116,573 $30.4 Million
Q3 2024 Nov 14, 2024	SELL	$15.71 - $23.49 $54,953 - $82,168	-3,498 Reduced 0.18%	1,922,985 $43.4 Million
Q2 2024 Aug 13, 2024	BUY	$19.45 - $37.37 $34.9 Million - $67 Million	1,791,802 Added 1330.4%	1,926,483 $37.5 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $61,949 - $93,233	1,717 Added 1.29%	134,681 $5.05 Million
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $26,666 - $44,716	-777 Reduced 0.58%	132,964 $7.44 Million
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $12,258 - $18,894	-300 Reduced 0.22%	133,741 $5.52 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $195,940 - $309,411	5,546 Added 4.32%	134,041 $7.48 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $24,839 - $42,043	-1,018 Reduced 0.79%	128,495 $4.68 Million
Q3 2022 Nov 14, 2022	SELL	$28.48 - $52.59 $9.39 Million - $17.3 Million	-329,829 Reduced 71.8%	129,513 $3.69 Million
Q2 2022 Aug 12, 2022	SELL	$36.95 - $82.41 $3.53 Million - $7.86 Million	-95,411 Reduced 17.2%	459,342 $20.8 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $3.21 Million - $8.4 Million	57,624 Added 11.59%	554,753 $42.2 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $4.21 Million - $5.69 Million	-31,151 Reduced 5.9%	497,129 $74.1 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $1.5 Million - $1.98 Million	10,327 Added 1.99%	528,280 $76.9 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $2.72 Million - $4.1 Million	20,239 Added 4.07%	517,953 $101 Million
Q1 2021 May 14, 2021	SELL	$140.25 - $196.86 $17.3 Million - $24.3 Million	-123,394 Reduced 19.87%	497,714 $90.1 Million
Q4 2020 Mar 01, 2021	BUY	$126.47 - $163.7 $22.8 Million - $29.6 Million	180,577 Added 40.99%	621,108 $87.9 Million
Q3 2020 Nov 13, 2020	BUY	$87.44 - $125.0 $3.95 Million - $5.64 Million	45,150 Added 11.42%	440,531 $54.9 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $1.89 Million - $2.89 Million	32,389 Added 8.92%	395,381 $35.3 Million
Q1 2020 May 15, 2020	BUY	$51.57 - $106.62 $26,042 - $53,843	505 Added 0.14%	362,992 $22.6 Million
Q4 2019 Feb 14, 2020	BUY	$46.07 - $79.54 $8.19 Million - $14.1 Million	177,804 Added 96.28%	362,487 $27.6 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $9.23 Million - $11.5 Million	184,683 New	184,683 $9.31 Million

Others Institutions Holding TXG

# of Institutions

302

Shares Held

96.5M

Call Options Held

76.4K

Put Options Held

132K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.15B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc 10x Genomics, Inc. Transaction History